SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-036345
Filing Date
2020-11-12
Accepted
2020-11-12 07:15:37
Documents
56
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q0920_soligenix.htm 10-Q 619178
2 THIRD EXTENSION AND AMENDMENT TO LEASE f10q0920ex10-1_soligenix.htm EX-10.1 11662
3 CERTIFICATION f10q0920ex31-1_soligenix.htm EX-31.1 10325
4 CERTIFICATION f10q0920ex31-2_soligenix.htm EX-31.2 10326
5 CERTIFICATION f10q0920ex32-1_soligenix.htm EX-32.1 3888
6 CERTIFICATION f10q0920ex32-2_soligenix.htm EX-32.2 3982
7 GRAPHIC ex10-1_001.jpg GRAPHIC 12673
  Complete submission text file 0001213900-20-036345.txt   3472157

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE sngx-20200930.xml EX-101.INS 531089
9 XBRL SCHEMA FILE sngx-20200930.xsd EX-101.SCH 48865
10 XBRL CALCULATION FILE sngx-20200930_cal.xml EX-101.CAL 35044
11 XBRL DEFINITION FILE sngx-20200930_def.xml EX-101.DEF 184852
12 XBRL LABEL FILE sngx-20200930_lab.xml EX-101.LAB 383665
13 XBRL PRESENTATION FILE sngx-20200930_pre.xml EX-101.PRE 195658
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 201303337
SIC: 2834 Pharmaceutical Preparations